Arkolith/Insider Trading/PHAT/Form 4

Topper James N

DirectorPhathom Pharmaceuticals, Inc. (PHAT) · full profile →Form 4 · filed May 15, 2025
Net Buying
Open-Market Buys
$24K
Open-Market Sells
$0
Net Open-Market Flow
$24K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 14, 2025Buy(P)6K$3.32$21K56K
May 13, 2025Buy(P)1K$3.16$4K49K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-013134) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML